| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | calcium-dependent cysteine-type endopeptidase activity | 1.89e-06 | 17 | 109 | 4 | GO:0004198 | |
| GeneOntologyMolecularFunction | calcium ion binding | UNC13B AMY2A AOC1 CAPN1 CAPN2 CAPN3 BCAN LRP1B CAPN8 CDH24 CDH22 CDH20 LRP1 MACF1 C1S CDH12 | 3.02e-06 | 749 | 109 | 16 | GO:0005509 |
| GeneOntologyMolecularFunction | BMP receptor binding | 4.35e-05 | 13 | 109 | 3 | GO:0070700 | |
| GeneOntologyMolecularFunction | low-density lipoprotein particle receptor activity | 8.41e-05 | 16 | 109 | 3 | GO:0005041 | |
| GeneOntologyMolecularFunction | hexosyltransferase activity | 1.60e-04 | 211 | 109 | 7 | GO:0016758 | |
| GeneOntologyMolecularFunction | glycosyltransferase activity | 1.83e-04 | 288 | 109 | 8 | GO:0016757 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor activity | 1.96e-04 | 21 | 109 | 3 | GO:0030228 | |
| GeneOntologyMolecularFunction | histone H3K27me2/H3K27me3 demethylase activity | 2.92e-04 | 5 | 109 | 2 | GO:0071558 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein serine/threonine kinase binding | 4.21e-04 | 27 | 109 | 3 | GO:0070696 | |
| GeneOntologyMolecularFunction | cadherin binding | 5.46e-04 | 339 | 109 | 8 | GO:0045296 | |
| GeneOntologyMolecularFunction | endopeptidase activity | 5.85e-04 | 430 | 109 | 9 | GO:0004175 | |
| GeneOntologyMolecularFunction | peptidase activity | 8.97e-04 | 654 | 109 | 11 | GO:0008233 | |
| GeneOntologyMolecularFunction | receptor serine/threonine kinase binding | 9.12e-04 | 35 | 109 | 3 | GO:0033612 | |
| GeneOntologyMolecularFunction | cysteine-type endopeptidase activity | 1.26e-03 | 86 | 109 | 4 | GO:0004197 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion mediated by cadherin | 6.59e-06 | 50 | 109 | 5 | GO:0044331 | |
| GeneOntologyBiologicalProcess | regulation of aldosterone biosynthetic process | 7.89e-06 | 8 | 109 | 3 | GO:0032347 | |
| GeneOntologyBiologicalProcess | regulation of aldosterone metabolic process | 1.18e-05 | 9 | 109 | 3 | GO:0032344 | |
| GeneOntologyBiologicalProcess | cell junction organization | UNC13B CACNA1S SDK2 HTR4 ITGA6 BCAN NPTN BMP6 CDH24 CDH22 NF1 CDH20 LRP1 MACF1 IGSF9B TNR CDH12 | 1.36e-05 | 974 | 109 | 17 | GO:0034330 |
| GeneOntologyBiologicalProcess | adherens junction organization | 1.77e-05 | 61 | 109 | 5 | GO:0034332 | |
| GeneOntologyBiologicalProcess | aldosterone biosynthetic process | 2.30e-05 | 11 | 109 | 3 | GO:0032342 | |
| GeneOntologyBiologicalProcess | calcium-dependent self proteolysis | 2.77e-05 | 2 | 109 | 2 | GO:1990092 | |
| GeneOntologyBiologicalProcess | mineralocorticoid biosynthetic process | 3.95e-05 | 13 | 109 | 3 | GO:0006705 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion | SDK2 CAPN1 ITGA6 BMP2 NPTN BMP5 BMP6 CDH24 CDH22 CDH20 BTNL2 FUT9 LRP6 IGSF9B TNR ALOX12 CDH12 | 4.87e-05 | 1077 | 109 | 17 | GO:0098609 |
| GeneOntologyBiologicalProcess | primary alcohol biosynthetic process | 5.01e-05 | 14 | 109 | 3 | GO:0034309 | |
| GeneOntologyBiologicalProcess | aldosterone metabolic process | 5.01e-05 | 14 | 109 | 3 | GO:0032341 | |
| GeneOntologyBiologicalProcess | positive regulation of neuron projection development | 5.36e-05 | 249 | 109 | 8 | GO:0010976 | |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | 6.15e-05 | 187 | 109 | 7 | GO:0007156 | |
| GeneOntologyBiologicalProcess | self proteolysis | 6.24e-05 | 15 | 109 | 3 | GO:0097264 | |
| GeneOntologyBiologicalProcess | mineralocorticoid metabolic process | 9.25e-05 | 17 | 109 | 3 | GO:0008212 | |
| GeneOntologyBiologicalProcess | leukocyte migration | 1.35e-04 | 449 | 109 | 10 | GO:0050900 | |
| GeneOntologyBiologicalProcess | negative regulation of hydrogen peroxide biosynthetic process | 1.65e-04 | 4 | 109 | 2 | GO:0010730 | |
| GeneOntologyBiologicalProcess | negative regulation of cortisol biosynthetic process | 1.65e-04 | 4 | 109 | 2 | GO:2000065 | |
| GeneOntologyBiologicalProcess | regulation of axon extension involved in regeneration | 1.65e-04 | 4 | 109 | 2 | GO:0048690 | |
| GeneOntologyBiologicalProcess | negative regulation of aldosterone metabolic process | 1.65e-04 | 4 | 109 | 2 | GO:0032345 | |
| GeneOntologyBiologicalProcess | negative regulation of aldosterone biosynthetic process | 1.65e-04 | 4 | 109 | 2 | GO:0032348 | |
| GeneOntologyBiologicalProcess | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules | 1.77e-04 | 53 | 109 | 4 | GO:0016339 | |
| GeneOntologyBiologicalProcess | endocrine system development | 2.15e-04 | 161 | 109 | 6 | GO:0035270 | |
| GeneOntologyBiologicalProcess | eye development | 2.31e-04 | 480 | 109 | 10 | GO:0001654 | |
| GeneOntologyBiologicalProcess | positive regulation of vascular permeability | 2.35e-04 | 23 | 109 | 3 | GO:0043117 | |
| GeneOntologyBiologicalProcess | protein O-linked glycosylation | 2.39e-04 | 105 | 109 | 5 | GO:0006493 | |
| GeneOntologyBiologicalProcess | visual system development | 2.43e-04 | 483 | 109 | 10 | GO:0150063 | |
| GeneOntologyBiologicalProcess | regulation of hormone metabolic process | 2.51e-04 | 58 | 109 | 4 | GO:0032350 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | 2.59e-04 | 313 | 109 | 8 | GO:0098742 | |
| GeneOntologyBiologicalProcess | regulation of steroid hormone biosynthetic process | 2.68e-04 | 24 | 109 | 3 | GO:0090030 | |
| GeneOntologyBiologicalProcess | response to abiotic stimulus | ABCA4 GRK4 CAPN2 CAPN3 BCL2L1 HMOX1 BDKRB1 STAT3 BMP2 NPTN BMP6 CLCA1 NF1 SCN9A TACR1 MME CTNS KDM6A | 2.68e-04 | 1361 | 109 | 18 | GO:0009628 |
| GeneOntologyBiologicalProcess | N-glycan fucosylation | 2.74e-04 | 5 | 109 | 2 | GO:0036071 | |
| GeneOntologyBiologicalProcess | axon extension involved in regeneration | 2.74e-04 | 5 | 109 | 2 | GO:0048677 | |
| GeneOntologyBiologicalProcess | regulation of sprouting of injured axon | 2.74e-04 | 5 | 109 | 2 | GO:0048686 | |
| GeneOntologyBiologicalProcess | negative regulation of glucocorticoid metabolic process | 2.74e-04 | 5 | 109 | 2 | GO:0031944 | |
| GeneOntologyBiologicalProcess | negative regulation of glucocorticoid biosynthetic process | 2.74e-04 | 5 | 109 | 2 | GO:0031947 | |
| GeneOntologyBiologicalProcess | sensory system development | 2.77e-04 | 491 | 109 | 10 | GO:0048880 | |
| GeneOntologyBiologicalProcess | positive regulation of cell projection organization | 2.91e-04 | 494 | 109 | 10 | GO:0031346 | |
| GeneOntologyBiologicalProcess | C21-steroid hormone biosynthetic process | 3.42e-04 | 26 | 109 | 3 | GO:0006700 | |
| GeneOntologyBiologicalProcess | regulation of ketone biosynthetic process | 3.42e-04 | 26 | 109 | 3 | GO:0010566 | |
| GeneOntologyBiologicalProcess | macromolecule glycosylation | 3.87e-04 | 252 | 109 | 7 | GO:0043413 | |
| GeneOntologyBiologicalProcess | protein glycosylation | 3.87e-04 | 252 | 109 | 7 | GO:0006486 | |
| GeneOntologyBiologicalProcess | regulation of neuron projection development | 3.97e-04 | 612 | 109 | 11 | GO:0010975 | |
| GeneOntologyBiologicalProcess | negative regulation of steroid hormone biosynthetic process | 4.09e-04 | 6 | 109 | 2 | GO:0090032 | |
| GeneOntologyBiologicalProcess | sprouting of injured axon | 4.09e-04 | 6 | 109 | 2 | GO:0048682 | |
| GeneOntologyBiologicalProcess | positive regulation of apoptotic process | UNC13B CAPN1 CAPN2 ITGA6 BCL2L1 HMOX1 BMP2 NF1 PIK3CD BUB1 LRP6 ALOX12 | 4.13e-04 | 718 | 109 | 12 | GO:0043065 |
| GeneOntologyBiologicalProcess | positive regulation of ossification | 4.13e-04 | 66 | 109 | 4 | GO:0045778 | |
| GeneOntologyBiologicalProcess | pericardium development | 4.27e-04 | 28 | 109 | 3 | GO:0060039 | |
| GeneOntologyBiologicalProcess | glycoprotein metabolic process | 4.64e-04 | 430 | 109 | 9 | GO:0009100 | |
| GeneOntologyBiologicalProcess | sensory organ development | CACNA1S SDK2 ZDHHC16 STAT3 SLC6A3 CRYBB2 BMP2 BMP5 BMP6 NF1 LRP6 CTNS | 4.79e-04 | 730 | 109 | 12 | GO:0007423 |
| GeneOntologyBiologicalProcess | positive regulation of cell population proliferation | CAPN1 VSTM2A BCAN BCL2L1 HMOX1 STAT3 BMP2 BMP5 BMP6 NF1 PIK3CD BTNL2 LRP6 TACR1 ALOX12 IL5RA | 5.09e-04 | 1190 | 109 | 16 | GO:0008284 |
| GeneOntologyBiologicalProcess | positive regulation of endothelial cell proliferation | 5.33e-04 | 125 | 109 | 5 | GO:0001938 | |
| GeneOntologyBiologicalProcess | positive regulation of programmed cell death | UNC13B CAPN1 CAPN2 ITGA6 BCL2L1 HMOX1 BMP2 NF1 PIK3CD BUB1 LRP6 ALOX12 | 5.34e-04 | 739 | 109 | 12 | GO:0043068 |
| GeneOntologyBiologicalProcess | regulation of leukocyte migration | 5.46e-04 | 267 | 109 | 7 | GO:0002685 | |
| GeneOntologyBiologicalProcess | regulation of cortisol biosynthetic process | 5.71e-04 | 7 | 109 | 2 | GO:2000064 | |
| GeneOntologyBiologicalProcess | aldehyde biosynthetic process | 5.79e-04 | 31 | 109 | 3 | GO:0046184 | |
| GeneOntologyBiologicalProcess | glycosylation | 5.83e-04 | 270 | 109 | 7 | GO:0070085 | |
| GeneOntologyBiologicalProcess | positive regulation of epithelial cell proliferation | 5.83e-04 | 270 | 109 | 7 | GO:0050679 | |
| GeneOntologyBiologicalProcess | glycoprotein biosynthetic process | 6.20e-04 | 357 | 109 | 8 | GO:0009101 | |
| GeneOntologyBiologicalProcess | behavioral response to pain | 6.37e-04 | 32 | 109 | 3 | GO:0048266 | |
| GeneOntologyBiologicalProcess | associative learning | 6.37e-04 | 130 | 109 | 5 | GO:0008306 | |
| GeneOntologyBiologicalProcess | negative regulation of hydrogen peroxide metabolic process | 7.59e-04 | 8 | 109 | 2 | GO:0010727 | |
| GeneOntologyBiologicalProcess | amyloid-beta clearance by cellular catabolic process | 7.59e-04 | 8 | 109 | 2 | GO:0150094 | |
| GeneOntologyBiologicalProcess | negative regulation of extrinsic apoptotic signaling pathway via death domain receptors | 7.62e-04 | 34 | 109 | 3 | GO:1902042 | |
| GeneOntologyBiologicalProcess | olefinic compound biosynthetic process | 8.31e-04 | 35 | 109 | 3 | GO:0120255 | |
| GeneOntologyBiologicalProcess | cell junction assembly | 8.72e-04 | 569 | 109 | 10 | GO:0034329 | |
| GeneOntologyBiologicalProcess | regulation of hormone biosynthetic process | 9.03e-04 | 36 | 109 | 3 | GO:0046885 | |
| GeneOntologyBiologicalProcess | regulation of muscle cell apoptotic process | 9.19e-04 | 141 | 109 | 5 | GO:0010660 | |
| GeneOntologyBiologicalProcess | L-fucose catabolic process | 9.72e-04 | 9 | 109 | 2 | GO:0042355 | |
| GeneOntologyBiologicalProcess | pericardium morphogenesis | 9.72e-04 | 9 | 109 | 2 | GO:0003344 | |
| GeneOntologyBiologicalProcess | fucose catabolic process | 9.72e-04 | 9 | 109 | 2 | GO:0019317 | |
| GeneOntologyBiologicalProcess | regulation of glucocorticoid biosynthetic process | 9.72e-04 | 9 | 109 | 2 | GO:0031946 | |
| GeneOntologyBiologicalProcess | regulation of hydrogen peroxide biosynthetic process | 1.21e-03 | 10 | 109 | 2 | GO:0010728 | |
| GeneOntologyBiologicalProcess | cortisol biosynthetic process | 1.21e-03 | 10 | 109 | 2 | GO:0034651 | |
| GeneOntologyBiologicalProcess | L-fucose metabolic process | 1.21e-03 | 10 | 109 | 2 | GO:0042354 | |
| GeneOntologyBiologicalProcess | positive regulation of inhibitory postsynaptic potential | 1.21e-03 | 10 | 109 | 2 | GO:0097151 | |
| GeneOntologyBiologicalProcess | renal water absorption | 1.21e-03 | 10 | 109 | 2 | GO:0070295 | |
| GeneOntologyBiologicalProcess | tertiary alcohol biosynthetic process | 1.21e-03 | 10 | 109 | 2 | GO:1902645 | |
| GeneOntologyBiologicalProcess | muscle cell apoptotic process | 1.21e-03 | 150 | 109 | 5 | GO:0010657 | |
| GeneOntologyBiologicalProcess | anterograde trans-synaptic signaling | UNC13B HTR4 BCL2L1 CHRM1 STAT3 SLC6A3 NPTN NF1 LRP6 IGSF9B TACR1 MME TNR | 1.26e-03 | 931 | 109 | 13 | GO:0098916 |
| GeneOntologyBiologicalProcess | chemical synaptic transmission | UNC13B HTR4 BCL2L1 CHRM1 STAT3 SLC6A3 NPTN NF1 LRP6 IGSF9B TACR1 MME TNR | 1.26e-03 | 931 | 109 | 13 | GO:0007268 |
| GeneOntologyBiologicalProcess | regulation of SMAD protein signal transduction | 1.33e-03 | 90 | 109 | 4 | GO:0060390 | |
| GeneOntologyBiologicalProcess | multicellular organismal-level chemical homeostasis | 1.33e-03 | 90 | 109 | 4 | GO:0140962 | |
| GeneOntologyBiologicalProcess | trans-synaptic signaling | UNC13B HTR4 BCL2L1 CHRM1 STAT3 SLC6A3 NPTN NF1 LRP6 IGSF9B TACR1 MME TNR | 1.36e-03 | 939 | 109 | 13 | GO:0099537 |
| GeneOntologyCellularComponent | cell surface | ISLR2 PRSS8 CAPN2 ITGA6 BCAN FCRLA SLC6A3 BMP2 NPTN BTNL3 BTNL2 LRP1 LRP6 ROS1 TACR1 MME TNR IL5RA | 1.48e-05 | 1111 | 108 | 18 | GO:0009986 |
| GeneOntologyCellularComponent | catenin complex | 2.17e-05 | 32 | 108 | 4 | GO:0016342 | |
| GeneOntologyCellularComponent | calpain complex | 1.58e-04 | 4 | 108 | 2 | GO:0110158 | |
| GeneOntologyCellularComponent | dendrite | CACNA1S HTR4 PLXDC1 GRK4 CAPN2 BCAN CHRM1 NPTN NF1 LRP1 IGSF9B TACR1 MME | 4.82e-04 | 858 | 108 | 13 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | CACNA1S HTR4 PLXDC1 GRK4 CAPN2 BCAN CHRM1 NPTN NF1 LRP1 IGSF9B TACR1 MME | 4.92e-04 | 860 | 108 | 13 | GO:0097447 |
| GeneOntologyCellularComponent | anchoring junction | AOC1 PLXDC1 CAPN1 CAPN2 OBSCN ITGA6 AQP7P3 TWF1 CDH24 CDH22 CDH20 LRP1 MME CDH12 | 5.00e-04 | 976 | 108 | 14 | GO:0070161 |
| GeneOntologyCellularComponent | cell-cell junction | 9.78e-04 | 591 | 108 | 10 | GO:0005911 | |
| GeneOntologyCellularComponent | perineuronal net | 1.16e-03 | 10 | 108 | 2 | GO:0072534 | |
| GeneOntologyCellularComponent | inner dynein arm | 1.16e-03 | 10 | 108 | 2 | GO:0036156 | |
| GeneOntologyCellularComponent | caspase complex | 1.16e-03 | 10 | 108 | 2 | GO:0008303 | |
| GeneOntologyCellularComponent | perisynaptic extracellular matrix | 1.41e-03 | 11 | 108 | 2 | GO:0098966 | |
| GeneOntologyCellularComponent | somatodendritic compartment | CACNA1S HTR4 PLXDC1 GRK4 CAPN2 BCAN CHRM1 SLC6A3 NPTN NF1 LRP1 LRP6 IGSF9B TACR1 MME | 1.61e-03 | 1228 | 108 | 15 | GO:0036477 |
| GeneOntologyCellularComponent | MLL3/4 complex | 1.69e-03 | 12 | 108 | 2 | GO:0044666 | |
| GeneOntologyCellularComponent | synapse-associated extracellular matrix | 1.99e-03 | 13 | 108 | 2 | GO:0099535 | |
| GeneOntologyCellularComponent | plasma membrane protein complex | CACNA1S ITGA6 SLC6A3 BMP2 CDH24 CDH22 CDH20 SCN9A LRP1 LRP6 CDH12 | 2.46e-03 | 785 | 108 | 11 | GO:0098797 |
| GeneOntologyCellularComponent | dynein complex | 2.75e-03 | 54 | 108 | 3 | GO:0030286 | |
| GeneOntologyCellularComponent | membrane raft | 2.76e-03 | 362 | 108 | 7 | GO:0045121 | |
| GeneOntologyCellularComponent | membrane microdomain | 2.84e-03 | 364 | 108 | 7 | GO:0098857 | |
| Domain | calpain_III | 4.86e-07 | 12 | 107 | 4 | SM00720 | |
| Domain | C2_III | 4.86e-07 | 12 | 107 | 4 | IPR033883 | |
| Domain | Calpain_III | 4.86e-07 | 12 | 107 | 4 | IPR022683 | |
| Domain | Calpain_III | 7.00e-07 | 13 | 107 | 4 | PF01067 | |
| Domain | Calpain_domain_III | 7.00e-07 | 13 | 107 | 4 | IPR022682 | |
| Domain | Calpain_cysteine_protease | 9.75e-07 | 14 | 107 | 4 | IPR022684 | |
| Domain | Peptidase_C2 | 1.32e-06 | 15 | 107 | 4 | PF00648 | |
| Domain | LY | 1.32e-06 | 15 | 107 | 4 | SM00135 | |
| Domain | CysPc | 1.32e-06 | 15 | 107 | 4 | SM00230 | |
| Domain | Peptidase_C2_calpain_cat | 1.32e-06 | 15 | 107 | 4 | IPR001300 | |
| Domain | CALPAIN_CAT | 1.32e-06 | 15 | 107 | 4 | PS50203 | |
| Domain | LDLR_classB_rpt | 1.32e-06 | 15 | 107 | 4 | IPR000033 | |
| Domain | Cadherin_C | 1.17e-05 | 25 | 107 | 4 | PF01049 | |
| Domain | Cadherin_cytoplasmic-dom | 1.17e-05 | 25 | 107 | 4 | IPR000233 | |
| Domain | THIOL_PROTEASE_CYS | 1.38e-05 | 26 | 107 | 4 | PS00139 | |
| Domain | THIOL_PROTEASE_ASN | 1.61e-05 | 27 | 107 | 4 | PS00640 | |
| Domain | THIOL_PROTEASE_HIS | 1.61e-05 | 27 | 107 | 4 | PS00639 | |
| Domain | Pept_cys_AS | 1.88e-05 | 28 | 107 | 4 | IPR000169 | |
| Domain | Catenin_binding_dom | 2.17e-05 | 29 | 107 | 4 | IPR027397 | |
| Domain | - | 2.17e-05 | 29 | 107 | 4 | 4.10.900.10 | |
| Domain | - | ISLR2 SDK2 VSTM2A OBSCN BCAN FCRLA NPTN BTNL3 BTNL2 ROS1 TGM7 IGSF9B TNR IL5RA | 2.54e-05 | 663 | 107 | 14 | 2.60.40.10 |
| Domain | DUF5050 | 3.25e-05 | 2 | 107 | 2 | IPR032485 | |
| Domain | DUF5050 | 3.25e-05 | 2 | 107 | 2 | PF16472 | |
| Domain | Ig-like_fold | ISLR2 SDK2 VSTM2A OBSCN BCAN FCRLA NPTN BTNL3 BTNL2 ROS1 TGM7 IGSF9B TNR IL5RA | 5.04e-05 | 706 | 107 | 14 | IPR013783 |
| Domain | Ldl_recept_b | 6.36e-05 | 14 | 107 | 3 | PF00058 | |
| Domain | LDLRB | 6.36e-05 | 14 | 107 | 3 | PS51120 | |
| Domain | IGv | 7.05e-05 | 75 | 107 | 5 | SM00406 | |
| Domain | - | 7.18e-05 | 39 | 107 | 4 | 2.120.10.30 | |
| Domain | 6-blade_b-propeller_TolB-like | 1.38e-04 | 46 | 107 | 4 | IPR011042 | |
| Domain | IG | 1.53e-04 | 421 | 107 | 10 | SM00409 | |
| Domain | Ig_sub | 1.53e-04 | 421 | 107 | 10 | IPR003599 | |
| Domain | EF-hand-dom_pair | 2.47e-04 | 287 | 107 | 8 | IPR011992 | |
| Domain | IG_LIKE | 5.18e-04 | 491 | 107 | 10 | PS50835 | |
| Domain | TGFb_propeptide | 5.40e-04 | 28 | 107 | 3 | PF00688 | |
| Domain | TGF-b_N | 5.40e-04 | 28 | 107 | 3 | IPR001111 | |
| Domain | Ig-like_dom | 6.25e-04 | 503 | 107 | 10 | IPR007110 | |
| Domain | EGF | 7.92e-04 | 126 | 107 | 5 | PF00008 | |
| Domain | TGF-beta-rel | 8.03e-04 | 32 | 107 | 3 | IPR015615 | |
| Domain | TGFb_CS | 8.03e-04 | 32 | 107 | 3 | IPR017948 | |
| Domain | EF-hand_8 | 9.61e-04 | 34 | 107 | 3 | PF13833 | |
| Domain | FN3 | 1.01e-03 | 199 | 107 | 6 | PS50853 | |
| Domain | Ig_V-set | 1.01e-03 | 199 | 107 | 6 | IPR013106 | |
| Domain | TGF-b_C | 1.23e-03 | 37 | 107 | 3 | IPR001839 | |
| Domain | TGF_BETA_1 | 1.23e-03 | 37 | 107 | 3 | PS00250 | |
| Domain | TGFB | 1.23e-03 | 37 | 107 | 3 | SM00204 | |
| Domain | TGF_BETA_2 | 1.23e-03 | 37 | 107 | 3 | PS51362 | |
| Domain | TGF_beta | 1.23e-03 | 37 | 107 | 3 | PF00019 | |
| Domain | FN3_dom | 1.29e-03 | 209 | 107 | 6 | IPR003961 | |
| Domain | LDLR_class-A_CS | 1.55e-03 | 40 | 107 | 3 | IPR023415 | |
| Domain | EFh | 2.16e-03 | 158 | 107 | 5 | SM00054 | |
| Domain | Ldl_recept_a | 2.18e-03 | 45 | 107 | 3 | PF00057 | |
| Domain | - | 2.32e-03 | 46 | 107 | 3 | 4.10.400.10 | |
| Domain | EGF_3 | 2.34e-03 | 235 | 107 | 6 | PS50026 | |
| Domain | fn3 | 2.41e-03 | 162 | 107 | 5 | PF00041 | |
| Domain | LDLRA_1 | 2.62e-03 | 48 | 107 | 3 | PS01209 | |
| Domain | LDrepeatLR_classA_rpt | 2.78e-03 | 49 | 107 | 3 | IPR002172 | |
| Domain | LDLa | 2.78e-03 | 49 | 107 | 3 | SM00192 | |
| Domain | LDLRA_2 | 2.78e-03 | 49 | 107 | 3 | PS50068 | |
| Domain | Dynein_HC_stalk | 2.83e-03 | 14 | 107 | 2 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 2.83e-03 | 14 | 107 | 2 | IPR013602 | |
| Domain | DHC_N2 | 2.83e-03 | 14 | 107 | 2 | PF08393 | |
| Domain | CS | 2.83e-03 | 14 | 107 | 2 | PF04969 | |
| Domain | MT | 2.83e-03 | 14 | 107 | 2 | PF12777 | |
| Domain | EGF-like_dom | 3.11e-03 | 249 | 107 | 6 | IPR000742 | |
| Domain | DHC_fam | 3.25e-03 | 15 | 107 | 2 | IPR026983 | |
| Domain | Dynein_heavy | 3.25e-03 | 15 | 107 | 2 | PF03028 | |
| Domain | Carbonic_anhydrase_a-class | 3.25e-03 | 15 | 107 | 2 | IPR023561 | |
| Domain | Dynein_heavy_dom | 3.25e-03 | 15 | 107 | 2 | IPR004273 | |
| Domain | ALPHA_CA_1 | 3.25e-03 | 15 | 107 | 2 | PS00162 | |
| Domain | EF_Hand_1_Ca_BS | 3.36e-03 | 175 | 107 | 5 | IPR018247 | |
| Domain | EGF_1 | 3.50e-03 | 255 | 107 | 6 | PS00022 | |
| Domain | Cadherin_CS | 3.57e-03 | 109 | 107 | 4 | IPR020894 | |
| Domain | CS | 3.70e-03 | 16 | 107 | 2 | PS51203 | |
| Domain | CS_dom | 3.70e-03 | 16 | 107 | 2 | IPR007052 | |
| Domain | EGF-like_CS | 3.92e-03 | 261 | 107 | 6 | IPR013032 | |
| Domain | - | 3.92e-03 | 261 | 107 | 6 | 1.10.238.10 | |
| Domain | CADHERIN_1 | 4.06e-03 | 113 | 107 | 4 | PS00232 | |
| Domain | Cadherin | 4.06e-03 | 113 | 107 | 4 | PF00028 | |
| Domain | V-set | 4.16e-03 | 184 | 107 | 5 | PF07686 | |
| Domain | Carb_anhydrase | 4.18e-03 | 17 | 107 | 2 | PF00194 | |
| Domain | Carb_anhydrase | 4.18e-03 | 17 | 107 | 2 | SM01057 | |
| Domain | - | 4.18e-03 | 17 | 107 | 2 | 3.10.200.10 | |
| Domain | ALPHA_CA_2 | 4.18e-03 | 17 | 107 | 2 | PS51144 | |
| Domain | Carbonic_anhydrase_a | 4.18e-03 | 17 | 107 | 2 | IPR001148 | |
| Domain | CADHERIN_2 | 4.19e-03 | 114 | 107 | 4 | PS50268 | |
| Domain | - | 4.19e-03 | 114 | 107 | 4 | 2.60.40.60 | |
| Domain | EGF_2 | 4.22e-03 | 265 | 107 | 6 | PS01186 | |
| Domain | FN3 | 4.25e-03 | 185 | 107 | 5 | SM00060 | |
| Domain | CA | 4.33e-03 | 115 | 107 | 4 | SM00112 | |
| Domain | Cadherin-like | 4.46e-03 | 116 | 107 | 4 | IPR015919 | |
| Domain | NA_NEUROTRAN_SYMP_2 | 4.69e-03 | 18 | 107 | 2 | PS00754 | |
| Domain | Cadherin | 4.74e-03 | 118 | 107 | 4 | IPR002126 | |
| Domain | SNF | 5.22e-03 | 19 | 107 | 2 | PF00209 | |
| Domain | Na/ntran_symport | 5.22e-03 | 19 | 107 | 2 | IPR000175 | |
| Domain | NA_NEUROTRAN_SYMP_1 | 5.22e-03 | 19 | 107 | 2 | PS00610 | |
| Domain | NA_NEUROTRAN_SYMP_3 | 5.22e-03 | 19 | 107 | 2 | PS50267 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 2.70e-05 | 258 | 86 | 9 | MM14572 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 8.69e-05 | 300 | 86 | 9 | M610 | |
| Pathway | WP_ALZHEIMERS_DISEASE | 8.70e-05 | 74 | 86 | 5 | MM15962 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BMP_SIGNALING_PATHWAY_BMP_ANTAGONIST | 9.46e-05 | 15 | 86 | 3 | M47824 | |
| Pathway | WP_IL3_SIGNALING | 2.22e-04 | 49 | 86 | 4 | M39722 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BMP_SIGNALING_PATHWAY | 2.32e-04 | 20 | 86 | 3 | M47843 | |
| Pubmed | 3.08e-08 | 3 | 110 | 3 | 8954122 | ||
| Pubmed | 4.60e-08 | 12 | 110 | 4 | 22102170 | ||
| Pubmed | Calpain-mediated cleavage of Atg5 switches autophagy to apoptosis. | 1.23e-07 | 4 | 110 | 3 | 16998475 | |
| Pubmed | 1.23e-07 | 4 | 110 | 3 | 8738748 | ||
| Pubmed | Characterization of the calcium-dependent proteolytic system in a mouse muscle cell line. | 1.23e-07 | 4 | 110 | 3 | 11952156 | |
| Pubmed | 1.23e-07 | 4 | 110 | 3 | 12634108 | ||
| Pubmed | 1.23e-07 | 4 | 110 | 3 | 18380899 | ||
| Pubmed | Four genes for the calpain family locate on four distinct human chromosomes. | 1.23e-07 | 4 | 110 | 3 | 2209092 | |
| Pubmed | 3.06e-07 | 5 | 110 | 3 | 17066377 | ||
| Pubmed | 3.06e-07 | 5 | 110 | 3 | 17646163 | ||
| Pubmed | 3.06e-07 | 5 | 110 | 3 | 17897354 | ||
| Pubmed | Calpain translocation during muscle fiber necrosis and regeneration in dystrophin-deficient mice. | 3.06e-07 | 5 | 110 | 3 | 8806430 | |
| Pubmed | Expression of bone morphogenetic proteins in human metastatic prostate and breast cancer. | 3.06e-07 | 5 | 110 | 3 | 15861517 | |
| Pubmed | Ionomycin-activated calpain triggers apoptosis. A probable role for Bcl-2 family members. | 3.06e-07 | 5 | 110 | 3 | 12000759 | |
| Pubmed | CA11 DNHD1 ISLR2 SUMF2 ZDHHC16 BCAN FCRLA NUDT9 CA10 XYLT2 CDH24 BTNL3 IGSF9B MOGAT3 ENTPD8 | 5.22e-07 | 985 | 110 | 15 | 12975309 | |
| Pubmed | Bone morphogenetic protein signaling in the developing kidney: present and future. | 6.11e-07 | 6 | 110 | 3 | 18331343 | |
| Pubmed | 6.11e-07 | 6 | 110 | 3 | 9415424 | ||
| Pubmed | 6.11e-07 | 6 | 110 | 3 | 9056639 | ||
| Pubmed | 6.11e-07 | 6 | 110 | 3 | 7605753 | ||
| Pubmed | Osteocyte control of bone formation via sclerostin, a novel BMP antagonist. | 6.11e-07 | 6 | 110 | 3 | 14633986 | |
| Pubmed | Limbiting outgrowth: BMPs as negative regulators in limb development. | 1.07e-06 | 7 | 110 | 3 | 10462412 | |
| Pubmed | A mammalian serine/threonine kinase receptor specifically binds BMP-2 and BMP-4. | 1.07e-06 | 7 | 110 | 3 | 7811286 | |
| Pubmed | 1.07e-06 | 7 | 110 | 3 | 20962236 | ||
| Pubmed | Neuronal differentiation of precursors in the neocortical ventricular zone is triggered by BMP. | 1.07e-06 | 7 | 110 | 3 | 9786991 | |
| Pubmed | BMP7 functions predominantly as a heterodimer with BMP2 or BMP4 during mammalian embryogenesis. | 1.07e-06 | 7 | 110 | 3 | 31566563 | |
| Pubmed | 1.07e-06 | 7 | 110 | 3 | 9396712 | ||
| Pubmed | The enamel knot as a signaling center in the developing mouse tooth. | 1.70e-06 | 8 | 110 | 3 | 8808404 | |
| Pubmed | 1.70e-06 | 8 | 110 | 3 | 9473662 | ||
| Pubmed | Bone morphogenetic proteins (BMPs) as regulators of dorsal forebrain development. | 1.70e-06 | 8 | 110 | 3 | 9187146 | |
| Pubmed | 1.70e-06 | 8 | 110 | 3 | 9664685 | ||
| Pubmed | 2.55e-06 | 9 | 110 | 3 | 1460021 | ||
| Pubmed | 2.55e-06 | 9 | 110 | 3 | 14660436 | ||
| Pubmed | 2.89e-06 | 276 | 110 | 8 | 28319085 | ||
| Pubmed | 4.99e-06 | 11 | 110 | 3 | 24639464 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | POMT2 SUMF2 PLOD3 ITGA6 HMOX1 LRP1B XYLT2 SLC6A8 NPTN BMP6 NF1 A4GALT LRP1 LRP6 FUT8 | 5.93e-06 | 1201 | 110 | 15 | 35696571 |
| Pubmed | Apoptosis, proliferation and gene expression patterns in mouse developing tongue. | 8.60e-06 | 13 | 110 | 3 | 16151852 | |
| Pubmed | Bmp7 regulates germ cell proliferation in mouse fetal gonads. | 8.60e-06 | 13 | 110 | 3 | 18391523 | |
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 33196296 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 19584291 | ||
| Pubmed | Striking differences of LDL receptor-related protein 1B expression in mouse and human. | 9.91e-06 | 2 | 110 | 2 | 15963947 | |
| Pubmed | [Expression of calpain 1 and calpain 2 during the skin incised wound healing in mice]. | 9.91e-06 | 2 | 110 | 2 | 17619446 | |
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 19295178 | ||
| Pubmed | Calpain 1 and 2 are required for RNA replication of echovirus 1. | 9.91e-06 | 2 | 110 | 2 | 18032503 | |
| Pubmed | Calpain-2 participates in the process of calpain-1 inactivation. | 9.91e-06 | 2 | 110 | 2 | 33078830 | |
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 20213502 | ||
| Pubmed | Anxiety-like behavior in female mice is modulated by STAT3 signaling in midbrain dopamine neurons. | 9.91e-06 | 2 | 110 | 2 | 33872705 | |
| Pubmed | mu-Calpain and calpain-3 are not autolyzed with exhaustive exercise in humans. | 9.91e-06 | 2 | 110 | 2 | 16107503 | |
| Pubmed | An H-YDb epitope is encoded by a novel mouse Y chromosome gene. | 9.91e-06 | 2 | 110 | 2 | 8944031 | |
| Pubmed | Cloning of m-calpain 80 kD subunit from the axonal degeneration-resistant WLD(S) mouse mutant. | 9.91e-06 | 2 | 110 | 2 | 9669314 | |
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 18523255 | ||
| Pubmed | Vitamin D₃ regulation of body fat, cytokines, and calpain gene expression. | 9.91e-06 | 2 | 110 | 2 | 25520983 | |
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 27806939 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 15471877 | ||
| Pubmed | m-Calpain is required for preimplantation embryonic development in mice. | 9.91e-06 | 2 | 110 | 2 | 16433929 | |
| Pubmed | A Model of Differential Mammary Growth Initiation by Stat3 and Asymmetric Integrin-α6 Inheritance. | 9.91e-06 | 2 | 110 | 2 | 32187533 | |
| Pubmed | Calpains are required for invasive and metastatic potentials of human HCC cells. | 9.91e-06 | 2 | 110 | 2 | 23733271 | |
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 23292448 | ||
| Pubmed | Involvement of calpains in growth factor-mediated migration. | 9.91e-06 | 2 | 110 | 2 | 16971167 | |
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 29258546 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 28594313 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 17577985 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 22335024 | ||
| Pubmed | Leptin Suppresses the Rewarding Effects of Running via STAT3 Signaling in Dopamine Neurons. | 9.91e-06 | 2 | 110 | 2 | 26341832 | |
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 19781581 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 27185592 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 22432027 | ||
| Pubmed | Endothelial STAT3 is essential for the protective effects of HO-1 in oxidant-induced lung injury. | 9.91e-06 | 2 | 110 | 2 | 16971418 | |
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 17359359 | ||
| Pubmed | Truncation of human dopamine transporter by protease calpain. | 9.91e-06 | 2 | 110 | 2 | 18468730 | |
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 26893174 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 30177812 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 20193680 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 18648652 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 30442941 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 14980313 | ||
| Pubmed | Unveiling the association of STAT3 and HO-1 in prostate cancer: role beyond heme degradation. | 9.91e-06 | 2 | 110 | 2 | 23226098 | |
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 28580587 | ||
| Pubmed | Low density lipoprotein receptor related protein 1 and 6 gene variants and ischaemic stroke risk. | 9.91e-06 | 2 | 110 | 2 | 26031789 | |
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 22140070 | ||
| Pubmed | M-calpain levels increase during fusion of myoblasts in the mutant muscular dysgenesis (mdg) mouse. | 9.91e-06 | 2 | 110 | 2 | 10949052 | |
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 20567515 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 19194496 | ||
| Pubmed | BMP-2 induces motility and invasiveness by promoting colon cancer stemness through STAT3 activation. | 9.91e-06 | 2 | 110 | 2 | 26124007 | |
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 28002826 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 11311946 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 31520365 | ||
| Pubmed | Bone morphogenetic protein-2 and -6 heterodimer illustrates the nature of ligand-receptor assembly. | 9.91e-06 | 2 | 110 | 2 | 20484413 | |
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 18434530 | ||
| Pubmed | Calpain activation contributes to hyperglycaemia-induced apoptosis in cardiomyocytes. | 9.91e-06 | 2 | 110 | 2 | 19505932 | |
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 25043591 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 14558086 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 27533081 | ||
| Pubmed | Highly conserved structure in the promoter region of the gene for muscle-specific calpain, p94. | 9.91e-06 | 2 | 110 | 2 | 8997499 | |
| Pubmed | CA10 and CA11 negatively regulate neuronal activity-dependent growth of gliomas. | 9.91e-06 | 2 | 110 | 2 | 30636076 | |
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 15758204 | ||
| Pubmed | Lysine demethylases KDM6A and UTY: The X and Y of histone demethylation. | 9.91e-06 | 2 | 110 | 2 | 31097364 | |
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 27622212 | ||
| Pubmed | Bcl-XL and STAT3 mediate malignant actions of gamma-irradiation in lung cancer cells. | 9.91e-06 | 2 | 110 | 2 | 20331635 | |
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 20039267 | ||
| Pubmed | STAT3 inhibition reduces macrophage number and tumor growth in neurofibroma. | 9.91e-06 | 2 | 110 | 2 | 30542122 | |
| Cytoband | 17q21.33 | 2.95e-06 | 41 | 110 | 4 | 17q21.33 | |
| GeneFamily | CD molecules|Type II classical cadherins | 2.86e-07 | 13 | 83 | 4 | 1186 | |
| GeneFamily | C2 domain containing|Calpains | 5.42e-07 | 15 | 83 | 4 | 975 | |
| GeneFamily | Bone morphogenetic proteins|Astacins | 1.50e-05 | 11 | 83 | 3 | 455 | |
| GeneFamily | Low density lipoprotein receptors | 2.58e-05 | 13 | 83 | 3 | 634 | |
| GeneFamily | Adenosine receptors|V-set domain containing | 1.04e-04 | 163 | 83 | 6 | 590 | |
| GeneFamily | NudC family | 1.24e-04 | 4 | 83 | 2 | 1285 | |
| GeneFamily | Immunoglobulin like domain containing | 2.61e-04 | 193 | 83 | 6 | 594 | |
| GeneFamily | Fibronectin type III domain containing | 8.49e-04 | 160 | 83 | 5 | 555 | |
| GeneFamily | Fucosyltransferases|Blood group antigens | 1.57e-03 | 13 | 83 | 2 | 434 | |
| GeneFamily | Butyrophilins|V-set domain containing|C2-set domain containing | 2.10e-03 | 15 | 83 | 2 | 458 | |
| GeneFamily | Carbonic anhydrases | 3.04e-03 | 18 | 83 | 2 | 460 | |
| GeneFamily | EF-hand domain containing | 3.36e-03 | 219 | 83 | 5 | 863 | |
| GeneFamily | PHD finger proteins|Lysine demethylases | 5.38e-03 | 24 | 83 | 2 | 485 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 6.45e-03 | 161 | 83 | 4 | 593 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.56e-10 | 184 | 110 | 9 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.56e-10 | 184 | 110 | 9 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.56e-10 | 184 | 110 | 9 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.12e-09 | 162 | 110 | 8 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | droplet-Marrow-nan-24m-Lymphocytic-late_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.25e-08 | 174 | 110 | 8 | cdfc50e5383c8670ce5109736aff36406f46c03d | |
| ToppCell | E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal-Intermediate_Fibroblast|E16.5-samps / Age Group, Lineage, Cell class and subclass | 5.10e-08 | 137 | 110 | 7 | dd5364a1002650d21e0c83d8c701b5f7b09d1c19 | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.53e-08 | 145 | 110 | 7 | 96712c68ab759d7ade0d912581a1a7c25dc6def8 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.45e-07 | 199 | 110 | 7 | 333056c2abe9724efeab542c0365fcfe4eff8f18 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.45e-07 | 199 | 110 | 7 | 19a97e27a4758e794ce7246d295e112b47931a48 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.45e-07 | 199 | 110 | 7 | e60ecbb8fa7bcd3e2ce7d78f6efb2cfd1fd77698 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.42e-06 | 155 | 110 | 6 | 77fdae85d36efb776db977eb424b32487ef222e4 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.91e-06 | 160 | 110 | 6 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.91e-06 | 160 | 110 | 6 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.71e-06 | 174 | 110 | 6 | 7d4b860e05b5931f6f9d757a68f75ff35597a47a | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Non-keratinizing_Cervical_Squamous_Cell_Carcinoma-3|TCGA-Cervix / Sample_Type by Project: Shred V9 | 4.87e-06 | 175 | 110 | 6 | 0cc215109d9915af47e4d0a120ce2e46910715fa | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3-Exc_L2-3_LINC00507_RPL9P17|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.03e-06 | 176 | 110 | 6 | c7be4eaa5eb76ad9389fb9d15ad0934e88d267d1 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.20e-06 | 177 | 110 | 6 | 8b003ed7887479c3a010ef37dd981b748256bda7 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.72e-06 | 180 | 110 | 6 | 5391d23817f5cc88a0871ddb98968897c839f464 | |
| ToppCell | Severe-Lymphoid-pDC|Severe / Condition, Lineage, Cell class and cell subclass | 5.91e-06 | 181 | 110 | 6 | 2caecb7c5dcdad46fd02b4ffb73cb613ce835187 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Epithelial-Tuft-related|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.91e-06 | 181 | 110 | 6 | 1c04e53f46992a0aea9d3eee985681ec4e71f80d | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8|Liver / Manually curated celltypes from each tissue | 5.91e-06 | 181 | 110 | 6 | f2315414e714ac86211546a935660c4be6e85f1b | |
| ToppCell | Severe-Lymphoid-pDC-|Severe / Condition, Lineage, Cell class and cell subclass | 5.91e-06 | 181 | 110 | 6 | 277ce4c49121da0990a5933b19d2c6af9bbe253e | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Epithelial-Tuft-related-BEST4+_epithelial|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.91e-06 | 181 | 110 | 6 | 83adf61f44cebe9e75de175c5dc39237fbf9ed24 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.49e-06 | 184 | 110 | 6 | 30fddbc9696476d4d7f08e53f84ea994a4ed873a | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3-Exc_L2-3_LINC00507_RPL9P17|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.49e-06 | 184 | 110 | 6 | 96926efa220f03d0787322c9519bb9e8f64f74d0 | |
| ToppCell | ILEUM-inflamed-(8)_Fibroblast-(8)_Smooth_muscle_cells|(8)_Fibroblast / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 6.90e-06 | 186 | 110 | 6 | cacc2f0b2ed46516173b61ba1c5c226a2db7cddc | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.80e-06 | 190 | 110 | 6 | 6c7e1086c0a274cd5527c3104106e372811c9905 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-stromal_related|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.28e-06 | 192 | 110 | 6 | 8ad6678df89175c5a4a835c8566f1552df3c996e | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-stromal_related-ICC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.28e-06 | 192 | 110 | 6 | 2f5378ea0b2fb2f672a36585d375f675983363a1 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.53e-06 | 193 | 110 | 6 | bdb7401dd9059032f930f2b575f2ef8e504b6594 | |
| ToppCell | (01)_IL1RL1+-(1)_GFP|(01)_IL1RL1+ / shred by cell type by condition | 9.31e-06 | 196 | 110 | 6 | b598b1112242534e139318012b257ed3cb09da83 | |
| ToppCell | ASK440-Epithelial-Type_2|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 9.31e-06 | 196 | 110 | 6 | 754b4202b617165c6994a0b5a9b1e486dccdd44d | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.58e-06 | 197 | 110 | 6 | b8dc192fc98428bbb701cc2ea57fc8ad93397785 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-AT1/AT2-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.86e-06 | 198 | 110 | 6 | 691a2f1779225e5519155460eeb6a2aac5f67a92 | |
| ToppCell | severe-pDC|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 9.86e-06 | 198 | 110 | 6 | 3c4820a8391088682fb3e47b914f872533bae227 | |
| ToppCell | COVID-19-Epithelial-AT2,_AT1_cells|COVID-19 / Condition, Lineage and Cell class | 9.86e-06 | 198 | 110 | 6 | 7e6f089e71e70190ff8486341ab06719d7741467 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-AT1/AT2|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.86e-06 | 198 | 110 | 6 | aed0476248e9637897eefb1623ec4035f2dacd82 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-AT1/AT2|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 9.86e-06 | 198 | 110 | 6 | e115eea04012e9e492e923ed080e1723c38d14fd | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-AT1/AT2-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 9.86e-06 | 198 | 110 | 6 | 33d1e0b6f57663544bee0ffdde83a65da764d44c | |
| ToppCell | Severe_COVID-19-Epithelial-AT1/AT2|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 9.86e-06 | 198 | 110 | 6 | 43e33d28d9de5033bd00d39be953542a225236ed | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.01e-05 | 199 | 110 | 6 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.01e-05 | 199 | 110 | 6 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.01e-05 | 199 | 110 | 6 | 8b86c69aaf60feff53aa782559cfece7342a23de | |
| ToppCell | proximal-Epithelial-Signaling_Alveolar_Epithelial_Type_2-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.04e-05 | 200 | 110 | 6 | 7bd76884fcffdbd9b8d24f5b6b5187ad3963da5f | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-AT2-2|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.04e-05 | 200 | 110 | 6 | acc771a902cf2f060c3eb9aedb72a256f5778a6c | |
| ToppCell | Parenchyma_COVID-19-Epithelial-TX-AT2-2|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 1.04e-05 | 200 | 110 | 6 | ceb613ac6cdf0e3e6bb3f04d89034e18a524cefb | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_alveolar-AT2|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.04e-05 | 200 | 110 | 6 | b535323e18d9fb0dde1e0026df142c831e48c29f | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.04e-05 | 200 | 110 | 6 | ad777683adeb2ce45ade570386235e311fa7ea2d | |
| ToppCell | proximal-Epithelial-Signaling_Alveolar_Epithelial_Type_2|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.04e-05 | 200 | 110 | 6 | af57f837eb7f988d24fc4612d16d68121498f0b0 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 1.04e-05 | 200 | 110 | 6 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-AT2-2-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.04e-05 | 200 | 110 | 6 | eb44d1f80ecaac3a022cd04ab16dc36151e45488 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-mature_enterocytic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.04e-05 | 200 | 110 | 6 | 73bfdf068a8ecbefc1e6afe9686df73658ee042f | |
| ToppCell | proximal-3-Epithelial-Signaling_Alveolar_Epithelial_Type_2|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.04e-05 | 200 | 110 | 6 | 9c7859659843b1566bdf623b269b5e166c89d38c | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.22e-05 | 136 | 110 | 5 | 7cd22169fb71c6caf9feb203ad98be8480a54fba | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell-Degenerative_Ascending_Thin_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.93e-05 | 144 | 110 | 5 | 163c591fedad2beb7f92531e6240e9554f90ea40 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L5_IT-L5_IT_VISp_Col27a1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.03e-05 | 154 | 110 | 5 | d22902d2922784583f7016453768ed05b14b965e | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8|bone_marrow / Manually curated celltypes from each tissue | 4.29e-05 | 156 | 110 | 5 | 1545169694f686d28648a68b552c2ae606599d66 | |
| ToppCell | TCGA-Colorectal-Solid_Tissue_Normal-Colon_normal_tissue-Colon_normal_tissue-6|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 5.13e-05 | 162 | 110 | 5 | 7f9385aa749bfb2fa9fee6939fe46d946bc21d31 | |
| ToppCell | facs-Lung-24m-Hematologic-lymphocytic-plasma_cell-plasma_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.76e-05 | 166 | 110 | 5 | 139bf49eb3624d9eec7e8a2cb33d69716d63a7c5 | |
| ToppCell | facs-Lung-24m-Hematologic-lymphocytic-plasma_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.76e-05 | 166 | 110 | 5 | 85f59c3cc7db8863ec0044f1fcc14580834f830b | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Myeloid-Dendritic-conventional_dendritic_cell-DC_c1-CLEC9A|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.76e-05 | 166 | 110 | 5 | c8fd241088de27c6e741a5dfee3cd770183b6bcb | |
| ToppCell | facs-Lung-18m-Hematologic-lymphocytic-plasma_cell-plasma_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.93e-05 | 167 | 110 | 5 | 8ec7a98b542b134f48df8fbec351693cc5cfe55c | |
| ToppCell | facs-Lung-18m-Hematologic-lymphocytic-plasma_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.93e-05 | 167 | 110 | 5 | a9f28c4649ce344ae3ba3a3acb58da9c7efad901 | |
| ToppCell | facs-Lung-EPCAM-24m-Lymphocytic-plasma_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.10e-05 | 168 | 110 | 5 | 41da200bbff5c663c39f67c38d6d5f43b0ad9494 | |
| ToppCell | TCGA-Colorectal-Solid_Tissue_Normal-Rectum_normal_tissue-Rectum_normal_tissue-6|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 6.10e-05 | 168 | 110 | 5 | 5ce3129a023a48a3d7e6b9306c1fc5addfef9675 | |
| ToppCell | facs-Lung-EPCAM-24m-Lymphocytic-Plasma_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.10e-05 | 168 | 110 | 5 | a77259c13508f19186d7b0f80b34dc6d89497ab5 | |
| ToppCell | facs-Lung-EPCAM-18m-Lymphocytic-plasma_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.27e-05 | 169 | 110 | 5 | e348d9877a1bcad4f33dd7b2ce6cb0049583c4d2 | |
| ToppCell | NS-moderate-d_0-4-Epithelial-Squamous|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.27e-05 | 169 | 110 | 5 | 4a5d023ffcf83312d29b1d215eb6b744ef1a0777 | |
| ToppCell | TCGA-Colorectal-Solid_Tissue_Normal-Rectum_normal_tissue|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 6.27e-05 | 169 | 110 | 5 | 41cb92b0558f0d5a3e511058efd9110258b88ee3 | |
| ToppCell | TCGA-Colorectal-Solid_Tissue_Normal-Rectum_normal_tissue-Rectum_normal_tissue|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 6.27e-05 | 169 | 110 | 5 | 91f4b6a14708e701b2af22989004282041777491 | |
| ToppCell | facs-Lung-EPCAM-18m-Lymphocytic-Plasma_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.27e-05 | 169 | 110 | 5 | 3167ca0c826244280e0e07d1e02656cf5e4e75a5 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_KRT17|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.45e-05 | 170 | 110 | 5 | 84d49a1f2989d98bd0acf9ec2d59f1042fc0f55b | |
| ToppCell | TCGA-Colorectal-Solid_Tissue_Normal-Colon_normal_tissue|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 6.82e-05 | 172 | 110 | 5 | 94842346c84542a5243bd765e49f4af8bc5182db | |
| ToppCell | TCGA-Colorectal-Solid_Tissue_Normal-Colon_normal_tissue-Colon_normal_tissue|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 6.82e-05 | 172 | 110 | 5 | 5d654dd030ed22a701e15c5f09002951d99a52e8 | |
| ToppCell | PND07-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet-Megakaryocyte/Platelet_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.20e-05 | 174 | 110 | 5 | a3f4981b10afa9d41a1c66c7f98522a8a534f82b | |
| ToppCell | PND07-Immune-Immune_Myeloid-Megakaryocyte/Platelet|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.20e-05 | 174 | 110 | 5 | 6cc108dde4b3f98a78a6040280f0d5e4aaa5bd75 | |
| ToppCell | PND07-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.20e-05 | 174 | 110 | 5 | 4b8bc5568e36031c8ecf001bb646809038c23919 | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.40e-05 | 175 | 110 | 5 | 59249c9e83952d7277010e7be3c779e26399eb5d | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.40e-05 | 175 | 110 | 5 | b35cc1357495f2a03a6500f807c6e6f8c877734d | |
| ToppCell | NS-moderate-d_0-4-Epithelial-Ionocyte|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.40e-05 | 175 | 110 | 5 | a1e0a15c69211d6db2edeb101476f0f6e08b90c8 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.40e-05 | 175 | 110 | 5 | 284fdc7a9d303636a637041846850d19d114861a | |
| ToppCell | facs-Marrow-B-cells-24m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.40e-05 | 175 | 110 | 5 | 887e75fc90e59a6394d62f3c048a9cfdf6707725 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3-Exc_L2-3_LINC00507_RPL9P17|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.60e-05 | 176 | 110 | 5 | 07abf29d681abdd6c7cc87f9eaf9377e92ce212c | |
| ToppCell | droplet-Lung-LUNG-30m-Lymphocytic-Plasma_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.60e-05 | 176 | 110 | 5 | 606704098bfdf8bfef740a3544a372fae1e75969 | |
| ToppCell | droplet-Lung-LUNG-30m-Lymphocytic-plasma_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.60e-05 | 176 | 110 | 5 | acb9e29773030f6452a069f8f7e53eab68ab7bd3 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_B-B_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.81e-05 | 177 | 110 | 5 | b07e6139618d888a9fd7cf43cad0d86a3f63e09e | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_B-B_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.81e-05 | 177 | 110 | 5 | 6376ec12322c04d5d37ec2fdc376700464cbc7fb | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Epithelial-mature_enterocytic-Enterocyte|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.81e-05 | 177 | 110 | 5 | 1f5b6498364b2017c4d49cd337d6e91c8e4f840d | |
| ToppCell | droplet-Fat-Scat-21m-Hematologic-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.01e-05 | 92 | 110 | 4 | 246aebf5f17d50f67a7b48f713ea5043cefefb24 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.02e-05 | 178 | 110 | 5 | d3cbdec9d75f076e565baca05ede292cca7758a4 | |
| ToppCell | 15-Trachea-Epithelial-Goblet-like_secretory|Trachea / Age, Tissue, Lineage and Cell class | 8.02e-05 | 178 | 110 | 5 | f0557920b9b3e7c4f39938d1b524aa58711af4d2 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.02e-05 | 178 | 110 | 5 | 5d6297f34e104bacefb25c4e2338b50fe13dd19a | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6-Exc_L6_THEMIS_LINC00343|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.23e-05 | 179 | 110 | 5 | 065a50952e8703fa07767beb6b73a090bf378ca6 | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.45e-05 | 180 | 110 | 5 | 08ae0f5d95c45feba68ad99788f7af7ff4c979af | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L2-4_RORB_GRIK1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.45e-05 | 180 | 110 | 5 | fd8c2059fcb382ffbfe19e598e37a49e1d5637b5 | |
| ToppCell | moderate-Myeloid-pDC|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 8.45e-05 | 180 | 110 | 5 | 1d8df7df03a71f49d6683554d3c948ce90dda42e | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.67e-05 | 181 | 110 | 5 | 7286700396676fdc41d9723979b8b408177aceb9 | |
| ToppCell | droplet-Marrow-nan-21m-Lymphocytic-late_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.67e-05 | 181 | 110 | 5 | 97022416d0f5a5ba9c9bd5e70ce95cf4cb19af89 | |
| ToppCell | TCGA-Colorectal-Solid_Tissue_Normal|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 8.67e-05 | 181 | 110 | 5 | 88f6f56f5f58b479d5db91b32c45934c045f88ea | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L2-4_RORB_GRIK1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.67e-05 | 181 | 110 | 5 | 57994ff4ecffb15653aee00644d9f887f5e3461d | |
| Drug | Meglumine [6284-40-8]; Down 200; 20.4uM; MCF7; HT_HG-U133A | 5.06e-06 | 196 | 110 | 8 | 6445_DN | |
| Drug | Clonidine hydrochloride [4205-91-8]; Up 200; 15uM; PC3; HT_HG-U133A | 5.25e-06 | 197 | 110 | 8 | 4478_UP | |
| Drug | Hypertensin II | CAPN1 CPA3 HMOX1 LRP1B BDKRB1 STAT3 BMP6 PIK3CD LRP1 MME ALOX12 | 7.49e-06 | 429 | 110 | 11 | CID000025476 |
| Drug | SR 48968 | 8.98e-06 | 58 | 110 | 5 | CID000104974 | |
| Drug | viridine | 9.66e-06 | 28 | 110 | 4 | CID000060995 | |
| Disease | hereditary spastic paraplegia 76 (implicated_via_orthology) | 7.26e-10 | 5 | 104 | 4 | DOID:0110821 (implicated_via_orthology) | |
| Disease | Duchenne muscular dystrophy (implicated_via_orthology) | 1.71e-07 | 36 | 104 | 5 | DOID:11723 (implicated_via_orthology) | |
| Disease | hereditary spastic paraplegia (implicated_via_orthology) | 4.27e-07 | 43 | 104 | 5 | DOID:2476 (implicated_via_orthology) | |
| Disease | obesity (implicated_via_orthology) | 9.86e-07 | 215 | 104 | 8 | DOID:9970 (implicated_via_orthology) | |
| Disease | epilepsy (implicated_via_orthology) | 1.87e-06 | 163 | 104 | 7 | DOID:1826 (implicated_via_orthology) | |
| Disease | Kabuki syndrome (implicated_via_orthology) | 3.68e-05 | 3 | 104 | 2 | DOID:0060473 (implicated_via_orthology) | |
| Disease | triclosan measurement, 8-hydroxydeoxyguanosine measurement | 7.35e-05 | 4 | 104 | 2 | EFO_0801078, EFO_0801081 | |
| Disease | renal cell carcinoma (is_marker_for) | 9.26e-05 | 128 | 104 | 5 | DOID:4450 (is_marker_for) | |
| Disease | colon adenocarcinoma (is_implicated_in) | 1.04e-04 | 26 | 104 | 3 | DOID:234 (is_implicated_in) | |
| Disease | diabetes mellitus (implicated_via_orthology) | 1.04e-04 | 26 | 104 | 3 | DOID:9351 (implicated_via_orthology) | |
| Disease | attention deficit hyperactivity disorder (implicated_via_orthology) | 1.31e-04 | 28 | 104 | 3 | DOID:1094 (implicated_via_orthology) | |
| Disease | Colorectal Carcinoma | 1.91e-04 | 702 | 104 | 10 | C0009402 | |
| Disease | Malignant neoplasm of breast | ABCA4 OBSCN HMOX1 STAT3 SORCS1 SLC6A3 BMP2 NF1 CDH20 ZNF436 MACF1 MME | 4.05e-04 | 1074 | 104 | 12 | C0006142 |
| Disease | sciatic neuropathy (biomarker_via_orthology) | 4.24e-04 | 99 | 104 | 4 | DOID:11446 (biomarker_via_orthology) | |
| Disease | colitis (biomarker_via_orthology) | 4.42e-04 | 42 | 104 | 3 | DOID:0060180 (biomarker_via_orthology) | |
| Disease | Autoimmune Diseases | 4.42e-04 | 42 | 104 | 3 | C0004364 | |
| Disease | Memory Loss | 4.74e-04 | 43 | 104 | 3 | C0751295 | |
| Disease | Age-Related Memory Disorders | 4.74e-04 | 43 | 104 | 3 | C0751292 | |
| Disease | Memory Disorder, Spatial | 4.74e-04 | 43 | 104 | 3 | C0751294 | |
| Disease | Memory Disorder, Semantic | 4.74e-04 | 43 | 104 | 3 | C0751293 | |
| Disease | Memory Disorders | 4.74e-04 | 43 | 104 | 3 | C0025261 | |
| Disease | Memory impairment | 5.07e-04 | 44 | 104 | 3 | C0233794 | |
| Disease | Marfan syndrome (implicated_via_orthology) | 5.44e-04 | 10 | 104 | 2 | DOID:14323 (implicated_via_orthology) | |
| Disease | tooth agenesis (is_implicated_in) | 5.44e-04 | 10 | 104 | 2 | DOID:0050591 (is_implicated_in) | |
| Disease | alcohol use disorder (implicated_via_orthology) | 6.49e-04 | 195 | 104 | 5 | DOID:1574 (implicated_via_orthology) | |
| Disease | Hereditary hemochromatosis | 7.94e-04 | 12 | 104 | 2 | C0392514 | |
| Disease | Hemochromatosis | 7.94e-04 | 12 | 104 | 2 | C0018995 | |
| Disease | colorectal cancer (is_implicated_in) | 9.02e-04 | 121 | 104 | 4 | DOID:9256 (is_implicated_in) | |
| Disease | pulmonary hypertension (implicated_via_orthology) | 9.26e-04 | 54 | 104 | 3 | DOID:6432 (implicated_via_orthology) | |
| Disease | prostate carcinoma (is_implicated_in) | 9.36e-04 | 13 | 104 | 2 | DOID:10286 (is_implicated_in) | |
| Disease | Autosomal recessive limb-girdle muscular dystrophy | 1.09e-03 | 14 | 104 | 2 | cv:C2931907 | |
| Disease | colon cancer (is_marker_for) | 1.20e-03 | 59 | 104 | 3 | DOID:219 (is_marker_for) | |
| Disease | adverse effect, response to xenobiotic stimulus | 1.20e-03 | 59 | 104 | 3 | EFO_0009658, GO_0009410 | |
| Disease | high grade glioma (biomarker_via_orthology) | 1.25e-03 | 15 | 104 | 2 | DOID:3070 (biomarker_via_orthology) | |
| Disease | Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse | 1.43e-03 | 16 | 104 | 2 | C0334634 | |
| Disease | chronic obstructive pulmonary disease (is_implicated_in) | 1.45e-03 | 63 | 104 | 3 | DOID:3083 (is_implicated_in) | |
| Disease | Prostatic Neoplasms | 1.54e-03 | 616 | 104 | 8 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 1.54e-03 | 616 | 104 | 8 | C0376358 | |
| Disease | muscular dystrophy (is_implicated_in) | 1.62e-03 | 17 | 104 | 2 | DOID:9884 (is_implicated_in) | |
| Disease | ulcerative colitis (is_implicated_in) | 1.62e-03 | 17 | 104 | 2 | DOID:8577 (is_implicated_in) | |
| Disease | acute pancreatitis | 1.81e-03 | 18 | 104 | 2 | EFO_1000652 | |
| Disease | brain infarction | 1.81e-03 | 18 | 104 | 2 | EFO_0004277 | |
| Disease | hippuric acid measurement | 2.02e-03 | 19 | 104 | 2 | EFO_0010496 | |
| Disease | glucagon measurement | 2.19e-03 | 154 | 104 | 4 | EFO_0008463 | |
| Disease | prostate cancer (is_marker_for) | 2.29e-03 | 156 | 104 | 4 | DOID:10283 (is_marker_for) | |
| Disease | intellectual disability (implicated_via_orthology) | 2.39e-03 | 75 | 104 | 3 | DOID:1059 (implicated_via_orthology) | |
| Disease | Lung Injury | 2.47e-03 | 21 | 104 | 2 | C0273115 | |
| Disease | Chronic Lung Injury | 2.47e-03 | 21 | 104 | 2 | C2350344 | |
| Disease | systemising measurement | 2.47e-03 | 21 | 104 | 2 | EFO_0010221 | |
| Disease | Attention Deficit Disorder | 2.71e-03 | 22 | 104 | 2 | C0041671 | |
| Disease | Minimal Brain Dysfunction | 2.71e-03 | 22 | 104 | 2 | C1321905 | |
| Disease | N-glycan measurement | 2.71e-03 | 22 | 104 | 2 | EFO_0004999 | |
| Disease | sciatic neuropathy (implicated_via_orthology) | 2.97e-03 | 23 | 104 | 2 | DOID:11446 (implicated_via_orthology) | |
| Disease | exploratory eye movement measurement | 2.97e-03 | 81 | 104 | 3 | EFO_0007700 | |
| Disease | Cardiomegaly | 3.08e-03 | 82 | 104 | 3 | C0018800 | |
| Disease | Cardiac Hypertrophy | 3.08e-03 | 82 | 104 | 3 | C1383860 | |
| Disease | Attention deficit hyperactivity disorder | 3.23e-03 | 24 | 104 | 2 | C1263846 | |
| Disease | traumatic brain injury (biomarker_via_orthology) | 3.23e-03 | 24 | 104 | 2 | DOID:0081292 (biomarker_via_orthology) | |
| Disease | Noonan Syndrome | 3.23e-03 | 24 | 104 | 2 | C0028326 | |
| Disease | Allodynia | 3.30e-03 | 84 | 104 | 3 | C0458247 | |
| Disease | Mechanical Allodynia | 3.30e-03 | 84 | 104 | 3 | C2936719 | |
| Disease | Hyperalgesia, Secondary | 3.30e-03 | 84 | 104 | 3 | C0751212 | |
| Disease | Hyperalgesia, Primary | 3.30e-03 | 84 | 104 | 3 | C0751211 | |
| Disease | Hyperalgesia, Thermal | 3.30e-03 | 84 | 104 | 3 | C0751214 | |
| Disease | Tactile Allodynia | 3.30e-03 | 84 | 104 | 3 | C0751213 | |
| Disease | Hyperalgesia | 3.30e-03 | 84 | 104 | 3 | C0020429 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| YWVPCVWFTNLAAQA | 181 | Q8NFU0 | |
| IEEFLKFQNWDYWPR | 26 | Q96M60 | |
| FVLGLPFWAENIWNQ | 86 | P46663 | |
| HYWEVDVGQNVGWYV | 341 | Q6UXE8 | |
| KVPEDVQEYSWYWGA | 51 | A8MTB9 | |
| QFVFEKGEYPRWDSW | 71 | P43320 | |
| NDPLGEWERYIQWVE | 21 | O43683 | |
| WEEVGPQIWYFFDNS | 431 | P78363 | |
| ADWYAAVQGRWEPYL | 156 | Q9NPC4 | |
| ARGWFPEPQVYWEDI | 166 | Q9UIR0 | |
| QSLGFFWVKQQPWYE | 1021 | Q9H7F0 | |
| DSQVRQYFPETWLWD | 726 | A8K2U0 | |
| WIQENGGWDTFVELY | 181 | Q07817 | |
| SQEDQWYLDYPGDQW | 31 | Q6NUI1 | |
| FQFWQYGEWVEVVID | 141 | A6NHC0 | |
| PEDWWSYKDNLQGNF | 31 | O75493 | |
| WITGIYEFLQSWGPQ | 716 | Q96M86 | |
| PPGWQEEQAITWARY | 606 | P19801 | |
| FQLWQFGEWVDVVVD | 151 | P07384 | |
| LYVDFSDVGWNDWIV | 301 | P12643 | |
| VQWSRVEEGVNAYWF | 541 | Q6UXK2 | |
| LWNNEDPYGDIWLTD | 191 | Q6NSI4 | |
| NENVAIYNPFRPWWE | 61 | P04746 | |
| FLWSDGVPLLYENWN | 756 | Q96GW7 | |
| WQIFDNPVDWKEQYI | 531 | O60568 | |
| VEGIAVDWIGNNLYW | 601 | Q9NZR2 | |
| EGIAVDWIAGNIYWT | 1956 | Q9NZR2 | |
| PRDIAVDWVAGNIYW | 3971 | Q9NZR2 | |
| TPWGQWYQTLEEVFI | 16 | Q8WVJ2 | |
| YWWNAILEGEEPIDI | 271 | Q8IVD9 | |
| CGYLPQVNDWQEDWV | 151 | Q9HA64 | |
| APAQWRAESYGVWVA | 456 | Q5MY95 | |
| VDWIAGNIYWVESNL | 1351 | Q07954 | |
| VFSDGENLWWVPVVA | 246 | A6NL99 | |
| FNETTILVWVWPFGQ | 61 | Q9Y231 | |
| WFVVPEGYWGVLNDF | 1166 | O15550 | |
| GSWWPNLEDLYEANV | 1191 | O15550 | |
| WVWNQFFVIEEYAGP | 46 | Q86UP0 | |
| AFGTVWYELQARDWP | 806 | Q8IVT5 | |
| GWLVEWQDYKPVEYT | 86 | Q9BW91 | |
| GWPVATENWEQKYGA | 166 | P08473 | |
| IGIIEENWQLSQFWY | 41 | Q8WVE0 | |
| QPVGLTVFENWLYWI | 1146 | O75581 | |
| VAQYSGVPWWIILVA | 1046 | P23229 | |
| AAINQGQLDWYAWVP | 541 | P18054 | |
| GWSYLNTVERWDPQA | 571 | Q96PQ7 | |
| LVNQFWETYEELSPW | 5781 | Q9UPN3 | |
| VWLYVDWDTPNQGGR | 61 | Q86VF5 | |
| WYINGAAVQPDDSDW | 4466 | Q5VST9 | |
| LWSEWSQPIYVGNDE | 321 | Q01344 | |
| PVFNVDGYIWSWTKN | 216 | P15088 | |
| DVVWANEKAWFQTPY | 461 | Q9Y232 | |
| DVLYWVNDAIGNEWP | 296 | Q13698 | |
| VNDAIGNEWPWIYFV | 301 | Q13698 | |
| AWQDWPLTQVTFYRD | 101 | Q7L513 | |
| WVWNQFFVLEEYTGT | 61 | Q9HBT6 | |
| EEYPLAAQGFDWELW | 291 | Q6P9A2 | |
| ELYVSFQDLGWQDWI | 416 | P22004 | |
| WQDWIIAPKGYAANY | 426 | P22004 | |
| DNPWAGGALINEYWV | 456 | P09871 | |
| LWAPAILFWQYLVGE | 156 | P11229 | |
| DYTVPGQVWTAFLWL | 286 | Q13639 | |
| ADGGPWVQDVAYDLW | 176 | Q8J025 | |
| GWQDWIIAPEGYAAF | 366 | P22003 | |
| QDLAFWYGPRWQEVI | 91 | P09601 | |
| WVWNQFFVLEEYVGS | 56 | P55289 | |
| KRGWVWNQFFVVEEY | 61 | Q9UJ99 | |
| INQVIGWIYFVAWSI | 126 | O60931 | |
| YPEQGNWEASIWKFF | 231 | A6NNS2 | |
| EVVNNEKYTFSPDWW | 356 | P32298 | |
| FQFWQYGEWVEVVVD | 141 | P17655 | |
| QFWRYGEWVDVVIDD | 166 | P20807 | |
| GWWAYKEVVQGSFVP | 31 | Q9NS85 | |
| WVTYFNKPDIDAWEL | 56 | P20674 | |
| VWQEWYDLDSLEQFP | 3801 | Q8IVF4 | |
| QYWDVELGVTYIPWD | 591 | O95104 | |
| QKANPFYEEWWFLVV | 1921 | Q58EX2 | |
| WTFQVTIEGEWFYGP | 2346 | Q6ZTR5 | |
| DTDQWEFINGWYVLV | 336 | Q8IZK6 | |
| EIEWWDSYIIPNGFD | 386 | O43395 | |
| GDPAVWWVSQFVKYL | 321 | Q9BYC5 | |
| WQQFEPQLTLWDVFG | 371 | Q9HA92 | |
| CEWFVVPEDYWGVLN | 1111 | O14607 | |
| LGNVWEWTASPYQAA | 231 | Q8NBJ7 | |
| DFRVYLLGNPVVWWL | 586 | Q9UKY4 | |
| VQPAWQIVLWAAAYT | 26 | P25103 | |
| DPWNWLDFVVIVFAY | 186 | Q15858 | |
| QAFWECVVVAWVYGA | 486 | P48029 | |
| AVAGQWPWQVSITYE | 51 | Q16651 | |
| VEYWSSFDDIPWGNL | 291 | Q8IY50 | |
| WAPNFWALYNALDKV | 281 | Q9BVK2 | |
| LYIPGWIENDEIQWN | 696 | A8K7I4 | |
| IYFSQEEWEWLSPIQ | 21 | Q5HYK9 | |
| SVYLEIQWWFLRGPE | 56 | Q8TAG5 | |
| WGDLTAEEWVSYPLQ | 106 | Q9C0F3 | |
| LVVVFYELDWDEPQW | 96 | Q7Z392 | |
| WAPVTQELYWQIGIE | 241 | P20142 | |
| PGNLTYTWYWQDENV | 256 | Q9UPX0 | |
| RQFLAPWIESQDWAY | 31 | P40763 | |
| VDWYPWGQEAFDKAR | 81 | Q8TB22 | |
| YIFPDWANALGWVIA | 551 | Q01959 | |
| GSPTPEIQWWYAEVN | 56 | Q9Y639 | |
| VEVQWEPFSFSFDGW | 431 | Q92752 | |
| LEKAFWNWVENYPDE | 216 | P21359 | |
| QLGWEAWLQYSFPLQ | 156 | O00329 | |
| ELFELGPSAWQNWTY | 596 | P08922 | |
| YPAWFEQFVLQWLDE | 1061 | O14795 | |
| EPVYWLVDNVIRWFG | 66 | Q969W1 | |
| FVVQWDHVYLQGWED | 201 | Q8IUK5 | |
| WQLIQEGVVPNRFYW | 306 | Q8WY21 | |
| FITSWPWNYGQFEED | 176 | Q96PF1 | |
| YWVNDQHWVGQDGPI | 81 | Q9NQE7 | |
| EVPGWAWDFFINLSA | 316 | Q9H1B5 | |
| QNAQGYEWIFIAWSP | 76 | Q12792 | |
| QLENSLYWWGVVPFS | 486 | O95071 |